Table 1.
Participant characteristics at baseline.
Table 2.
Growth and gonadotropin levels at baseline, 12, 24 and 36 months.
Table 3.
Bone mineral density outcomes at baseline, 12, 24 and 36 months.
Table 4.
ASEBA outcomes at baseline, 12, 24 and 36 months.
Table 5.
Other psychological outcomes at baseline, 12, 24 and 36 months.
Table 6.
Associations between birth-registered sex and baseline pubertal status and outcomes at 12 months.
Fig 1.
Ratings of change in life overall, mood and friendships at 6–15 months (n = 41) and 15–24 months (n = 29).
Table 7.
Adverse events reported across the study.